1. Magne, Nathalie, Rousseau, Véronique, Duarte, Kévin, Sanson, Marc, Barnier, Jean-Vianney. 2021. PAK3 is a key signature gene of the glioma proneural subtype and affects its proliferation, differentiation and growth. In Cellular oncology (Dordrecht, Netherlands), 44, 1257-1271. doi:10.1007/s13402-021-00635-8. https://pubmed.ncbi.nlm.nih.gov/34550532/
2. Qian, Yanyan, Wu, Bingbing, Lu, Yulan, Wang, Sujuan, Wang, Huijun. 2020. Novel PAK3 gene missense variant associated with two Chinese siblings with intellectual disability: a case report. In BMC medical genetics, 21, 31. doi:10.1186/s12881-020-0957-x. https://pubmed.ncbi.nlm.nih.gov/32050918/
3. Chen, Xinyi, Ruiz-Velasco, Andrea, Zou, Zhiyong, Müller, Oliver J, Liu, Wei. . PAK3 Exacerbates Cardiac Lipotoxicity via SREBP1c in Obesity Cardiomyopathy. In Diabetes, 73, 1805-1820. doi:10.2337/db24-0240. https://pubmed.ncbi.nlm.nih.gov/39137120/
4. Castillon, Charlotte, Gonzalez, Laurine, Domenichini, Florence, Barnier, Jean-Vianney, Poirier, Roseline. . The intellectual disability PAK3 R67C mutation impacts cognitive functions and adult hippocampal neurogenesis. In Human molecular genetics, 29, 1950-1968. doi:10.1093/hmg/ddz296. https://pubmed.ncbi.nlm.nih.gov/31943058/
5. Holderness Parker, Nina, Donninger, Howard, Birrer, Michael J, Leaner, Virna D. 2013. p21-activated kinase 3 (PAK3) is an AP-1 regulated gene contributing to actin organisation and migration of transformed fibroblasts. In PloS one, 8, e66892. doi:10.1371/journal.pone.0066892. https://pubmed.ncbi.nlm.nih.gov/23818969/
6. Iida, Aritoshi, Takano, Kyoko, Takeshita, Eri, Inoue, Ken, Goto, Yu-Ichi. 2019. A novel PAK3 pathogenic variant identified in two siblings from a Japanese family with X-linked intellectual disability: case report and review of the literature. In Cold Spring Harbor molecular case studies, 5, . doi:10.1101/mcs.a003988. https://pubmed.ncbi.nlm.nih.gov/31444167/
智鼠故事 
